Jan Haudemann-Andersen, member of the board of Vaccibody AS, owns directly or indirectly Datum AS, Datum Invest AS, Datum Opportunity AS, Datum Vekst AS and Datum Finans AS.
 
The Datum Group has today, September 10, 2021, reallocated its shareholdings in Vaccibody AS:
 
Datum Invest AS has sold 5 000 000 shares at NOK 79 per share
Datum AS has sold 21 000 000 shares at NOK 79 per share
Datum Vekst AS has sold 2 395 500 shares at NOK 79 per share
Datum Opportunity AS has bought 26 000 000 shares at NOK 79 per share.
Datum Finans AS has bought 2 395 500 shares at NOK 79 per share.
 
Following the transactions, the companies’ shareholdings are:
 
Datum Invest AS - no shares 
Datum Vekst AS - no shares 
Datum AS - 11 634 250 shares
Datum Opportunity – 26 000 000 shares
Datum Finans AS – 2 395 500 shares
 
Jan Haudemann-Andersen and the Datum Group hold an unchanged number of 40 263 050 shares in Vaccibody AS after the above transactions.
 
Please see further details in attached document.